Cresco Labs (CSE:CL,OTCQX:CRLBF) has signed a sale-and-leaseback agreement for its cultivation facility in Lincoln, Illinois, in a bid to further solidify its balance sheet.

The firm announced on Thursday (December 12) that it is passing on the facility to GreenAcreage Real Estate for a price of US$50 million.


Concurrent to the closing of the deal, Cresco is entering into a triple-net lease agreement with GreenAcreage and will continue to keep up the facility’s medical and recreational cannabis operations.

“This agreement is representative of the comprehensive approach to capital planning that we anticipate will ensure our future success, while enabling us to grow our footprint both rapidly and responsibly,” said Cresco CEO Charlie Bachtell in a statement.

The executive added that the deal goes a long way to strengthening the company’s position in Illinois, a state that represents one of the largest opportunities for marijuana in the US as its recreational cannabis market goes online in the beginning of 2020. The state could generate up to US$2.5 billion annually in cannabis sales once legalization goes into effect, according to Marijuana Business Daily.

The company said that once completed, the Lincoln facility will span 220,000 square feet, making it the largest facility of its kind in the state. And with the increased production capacity, Cresco said it will be well positioned to increase its existing 25 percent market share in Illinois.

GreenAcreage Chief Investment Officer Jeffrey Lefleur told the Investing News Network (INN) that Illinois offers a particularly attractive opportunity for both cannabis operators and investors because of the existing support the marijuana space in the state already has.

Deals like this come at a particularly difficult time for cannabis companies, the executive said, as the companies struggle to fund their operations.

“The scarcity of capital in the cannabis space is amazing,” Lefleur told INN. “You have a tremendous amount of growth, tremendous cash burn and yet there is not enough capital to go around to support these companies.”

That’s where sale-and-leaseback agreements come in, he said.

Lefleur noted that most financing options available for cannabis companies involve some sort of equity dilution, something firms don’t have to face with leaseback deals.

“The idea of growing your company by constantly giving your company away really is not what’s in the best interest of these companies,” he said.

He described the deals as “a synthetic long-term debt market” that creates value where it currently doesn’t exist for marijuana companies.

Some experts have noted the less profitable aspects of these kinds of agreements, however.

Mike Regan, an analyst with Marijuana Business Daily’s Investor Intelligence, said that deals in the real estate realm are beneficial for cannabis companies since the drug’s illegality at the federal level bars businesses in the space from traditional bank-backed financing — but the deals come at a price.

“It becomes a higher operating cost that that company will incur for the term of the lease and some of these are 15 years, and they’re not very cheap,” Regan explained. “But that’s still cheaper than going out of business.”

The deal with GreenAcreage is Cresco’s second leaseback in its home state. In September, the firm signed an agreement to sell two of its properties in Illinois to Innovative Industrial Properties (IIP) (NYSE:IIPR) for US$46.3 million. Like the GreenAcreage deal, Cresco entered into a long-term triple-net lease agreement with IIP to continue the operations of the two facilities.

Cresco’s shares saw a jump of 8.6 percent early on in the trading day on Thursday following news of its agreement with GreenAcreage.

Image courtesy of Cresco Labs.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact ir@hillstreetbevco.com, or

Keep reading... Show less